By Associate Professor Meg Jardine

Book Chapters

Agarwal N; Guedes M; Pecoits-Filho R; Jardine M, 2024, 'Alternative klinische Studiendesigns für die Nephrologieforschung', in Innovationen in der Nephrologie, Springer Nature Switzerland, pp. 513 - 550, http://dx.doi.org/10.1007/978-3-031-65236-3_28

Agarwal N; Guedes M; Pecoits-Filho R; Jardine M, 2022, 'Alternative Clinical Trial Designs for Nephrology Research', in Innovations in Nephrology: Breakthrough Technologies in Kidney Disease Care, pp. 461 - 492, http://dx.doi.org/10.1007/978-3-031-11570-7_28

Smyth B; Hawley CM; Jardine M, 2022, 'Dialysis Dose and Adequacy for Hemodialysis', in Evidence-Based Nephrology, Second Edition: Volumes 1,2, pp. 20 - 33, http://dx.doi.org/10.1002/9781119105954.ch41

Foote C; Jardine MJ, 2014, 'Acute dialysis in older patients', in Managing Renal Injury in the Elderly Patient, pp. 59 - 71, http://dx.doi.org/10.1007/978-3-642-39947-3_7

Wang AY; Jardine M; Perkovic V, 2014, 'Kidney Disease in Diabetes', in Managing Cardiovascular Complications in Diabetes, pp. 58 - 86, http://dx.doi.org/10.1002/9781118337967.ch3

Wang Y; Ivany JN; Perkovic V; Gallagher MP; Jardine MJ, 2012, 'Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease', in Wang Y (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009631

Gangadharan Komala M; Pianta TJ; Jardine MJ; Webster AC; Perkovic V, 2011, 'Interventions for preventing intradialytic hypotension in haemodialysis patients', in Gangadharan Komala M (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd009459

Razavian M; Di Micco L; Palmer SC; Craig JC; Perkovic V; Zoungas S; Webster AC; Jardine MJ; Strippoli GFM, 2010, 'Antiplatelet agents for chronic kidney disease', in Palmer SC (ed.), , John Wiley & Sons, Ltd, http://dx.doi.org/10.1002/14651858.cd008834

Journal articles

Kotwal SS; Perkovic V; Jardine MJ; Kim D; Shah NA; Lin E; Coggan S; Billot L; Vart P; Wheeler DC; de Boer IH; Zhang H; Hou FF; Sugawara Y; Marion J; Lewis RJ; Berry LR; McGlothlin A; Jha V; De Nicola L; Gorriz JL; Heerspink HJL; GKPTN and CAPTIVATE Investigators , 2024, 'The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol.', JAMA Netw Open, 7, pp. e2449998, http://dx.doi.org/10.1001/jamanetworkopen.2024.49998

Neuen BL; Ostrominski JW; Claggett B; Beldhuis IE; Chatur S; McCausland FR; Badve SV; Arnott C; Heerspink HJL; Jun M; Falster M; de Oliveira Costa J; Pollock C; Jardine MJ; Mahaffey KW; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Bidirectional Relationship Between Kidney Disease Progression and Cardiovascular Events in Type 2 Diabetes', Journal of the American College of Cardiology, 84, pp. 2246 - 2250, http://dx.doi.org/10.1016/j.jacc.2024.08.006

Cooper M; Cherney DZI; Greene TH; Heerspink HJL; Jardine M; Lewis JB; Wong MG; Baquero E; Heise M; Jochems J; Lanchoney D; Liss C; Reiser D; Scotney P; Velkoska E; Dwyer JP, 2024, 'Vascular Endothelial Growth Factor-B Blockade with CSL346 in Diabetic Kidney Disease: A Phase 2A Randomized Controlled Trial', Journal of the American Society of Nephrology, 35, pp. 1546 - 1557, http://dx.doi.org/10.1681/ASN.0000000000000438

Neuen BL; Ostrominski JW; Claggett BL; Beldhuis I; Chatur S; Arnott C; Heerspink HJL; Pollock C; Jardine M; Mahaffey KW; Perkovic V; Solomon SD; Vaduganathan M, 2024, 'Bidirectional relationship between kidney disease progression and cardiovascular events in type 2 diabetes: new Insights from the CANVAS Program and CREDENCE trial', European Heart Journal, 45, http://dx.doi.org/10.1093/eurheartj/ehae666.3264

Chatur S; Neuen BL; Fletcher RA; Perkovic V; Heerspink H; Arnott C; Pollock C; Mahaffey KW; Neal B; Jardine M; Solomon SD; Vaduganathan M, 2024, 'Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: a participant level pooled analysis of CREDENCE and CANVAS', European Heart Journal, 45, http://dx.doi.org/10.1093/eurheartj/ehae666.1228

Heerspink HJL; Jardine M; Kohan DE; Lafayette RA; Levin A; Liew A; Zhang H; Lodha A; Gray T; Wang Y; Renfurm R; Barratt J; ALIGN Study Investigators , 2024, 'Atrasentan in Patients with IgA Nephropathy.', N Engl J Med, http://dx.doi.org/10.1056/NEJMoa2409415

O'Hara DV; Bassi A; Wilcox A; Jha V; Rathore V; D'Cruz S; Snelling TL; Jones M; Totterdell J; Bangi A; Jain MK; Pollock C; Burrell L; Fox G; Jones C; Kotwal S; Faridah Syed Omar S; Jardine M, 2024, 'Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial', BMJ open, 14, pp. e081790, http://dx.doi.org/10.1136/bmjopen-2023-081790

Li J; Lv J; Wong MG; Shi S; Zan J; Monaghan H; Perkovic V; Zhang H; Agarwal R; Barbour S; Cattran D; Cass A; Chan TM; Feehally J; Glassock R; Hladunewich MA; Hooi LS; Jardine MJ; Jha V; Johnson DW; Levin A; Liu ZH; Reich H; Remuzzi G; Wheeler DC; Wong MG; Woodward M; Wu Y; Zhao M, 2024, 'Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy', Kidney International Reports, 9, pp. 3016 - 3026, http://dx.doi.org/10.1016/j.ekir.2024.07.031

Koshino A; Heerspink HJL; Jongs N; Badve SV; Arnott C; Neal B; Jardine M; Mahaffey KW; Pollock C; Perkovic V; Hansen MK; Bakker SJL; Wada T; Neuen BL, 2024, 'Canagliflozin and iron metabolism in the CREDENCE trial.', Nephrol Dial Transplant, http://dx.doi.org/10.1093/ndt/gfae198

Vaduganathan M; Cannon CP; Jardine MJ; Heerspink HJL; Arnott C; Neuen BL; Sarraju A; Gogate J; Seufert J; Neal B; Perkovic V; Mahaffey KW; Kosiborod MN, 2024, 'Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trial', European Journal of Heart Failure, 26, pp. 1967 - 1975, http://dx.doi.org/10.1002/ejhf.3292

Fletcher RA; Herrington WG; Agarwal R; Mayne KJ; Arnott C; Jardine MJ; Mahaffey KW; Perkovic V; Staplin N; Wheeler DC; Chertow GM; Heerspink HJL; Neuen BL, 2024, 'Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD A Meta-Analysis of CKD Progression Trials', Clinical Journal of the American Society of Nephrology, 19, pp. 1180 - 1182, http://dx.doi.org/10.2215/CJN.0000000000000470

Junek ML; Merkel PA; Vilayur E; Wald R; Khalidi N; Jayne D; Walsh M; Paizis K; Reidlinger D; Morrish A; Badve SV; Pascoe E; Paul-Brent PA; Robison L; Valks A; Walters G; Jardine M; Milton C; Ibraham A; Siva B; Desmond M; Perkovic V; Kurtkoti J; Cass A; Summers S; Brown F; Ryan J; Kerr P; Noble E; Luxton G; Mudge DW; Hawley C; Johnson DW; Peh CA; Faull RJ; Ranganathan D; Jeffs L; Nicholls K; Hughes P; Cooper B; Boudville N; Ford S; Langham R; Blockmans D; Henckaerts L; Sprangers B; Suri R; Brachemi S; Clark W; Garg A; Carette S; Pagnoux C; Reich H; Barth D; Walsh M; Cox G; Mazzetti A; Robins D; Perl J; Pavenski K; Dacouris N; Levin A; Copland M; Fairhead T; Pannu N; Qarni MU; Habib S; Girard L; Manns B; Tesar V; Hruskova Z; Chocova Z; Povlsen J; Gregersen J; Ivarsen P; Birn H; Krarup E; Pedersen EB; Thomsen I; Bech JN; Szpirt W; Egfjord M; Mesbah R; Bataille P; Rey I; Gombert B; Chantrel F; Vanhille P; Quémeneur T; Carron PL; Zaoui P; de Moreuil C; Gosselin M; Delluc A; Hanrotel-Saliou C; Le Jeune M; Ficheux M, 2024, 'Risk of Relapse of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids', Arthritis and Rheumatology, 76, pp. 1431 - 1438, http://dx.doi.org/10.1002/art.42843

O’Hara DV; Lam CSP; McMurray JJV; Yi TW; Hocking S; Dawson J; Raichand S; Januszewski AS; Jardine MJ, 2024, 'Applications of SGLT2 inhibitors beyond glycaemic control', Nature Reviews Nephrology, 20, pp. 513 - 529, http://dx.doi.org/10.1038/s41581-024-00836-y

Chertow GM; Chang AM; Felker GM; Heise M; Velkoska E; Fellström B; Charytan DM; Clementi R; Gibson CM; Goodman SG; Jardine M; Levin A; Lokhnygina Y; Mears J; Mehran R; Stenvinkel P; Wang AYM; Wheeler DC; Zoccali C; Ridker PM; Mahaffey KW; Tricoci P; Wolf M, 2024, 'Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial(Nature Medicine, 10.1038/s41591-024-03043-1)', Nature Medicine, 30, pp. 2373, http://dx.doi.org/10.1038/s41591-024-03156-7

Apperloo EM; Neuen BL; Fletcher RA; Jongs N; Anker SD; Bhatt DL; Butler J; Cherney DZI; Herrington WG; Inzucchi SE; Jardine MJ; Liu CC; Mahaffey KW; McGuire DK; McMurray JJV; Neal B; Packer M; Perkovic V; Sabatine MS; Solomon SD; Staplin N; Szarek M; Vaduganathan M; Wanner C; Wheeler DC; Wiviott SD; Zannad F; Heerspink HJL, 2024, 'Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials', The Lancet Diabetes and Endocrinology, 12, pp. 545 - 557, http://dx.doi.org/10.1016/S2213-8587(24)00155-4

Chertow GM; Chang AM; Felker GM; Heise M; Velkoska E; Fellström B; Charytan DM; Clementi R; Gibson CM; Goodman SG; Jardine M; Levin A; Lokhnygina Y; Mears J; Mehran R; Stenvinkel P; Wang AYM; Wheeler DC; Zoccali C; Ridker PM; Mahaffey KW; Tricoci P; Wolf M, 2024, 'IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial', Nature Medicine, 30, pp. 2328 - 2336, http://dx.doi.org/10.1038/s41591-024-03043-1

Neuen BL; Claggett BL; Perkovic V; Jardine M; Heerspink HJL; Mahaffey KW; McMurray JJV; Solomon SD; Vaduganathan M, 2024, 'Timing of Cardio-Kidney Protection With SGLT2 Inhibitors: Insights From 4 Large-Scale Placebo-Controlled Outcome Trials', Circulation, 150, pp. 343 - 345, http://dx.doi.org/10.1161/CIRCULATIONAHA.124.069382

Collister D; Pyne L; Bhasin AA; Smyth B; Herrington W; Jardine M; Mark PB; Badve S; Rossignol P; Dember LM; Wanner C; Ezekowitz J; Devereaux PJ; Parfrey P; Gansevoort R; Walsh M, 2024, 'Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.', Nephrol Dial Transplant, http://dx.doi.org/10.1093/ndt/gfae156

O'Hara DV; Janse RJ; Fu EL; Jardine MJ; Carrero JJ, 2024, 'Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care', Diabetes Research and Clinical Practice, 213, http://dx.doi.org/10.1016/j.diabres.2024.111745

Pinter J; Jardine M; Canaud B; Genser B, 2024, 'Authors' Reply: Dialysate Sodium and Mortality: 140 mmol/L at Hemodialysis Initiation by Default?', Journal of the American Society of Nephrology, 35, pp. 974 - 975, http://dx.doi.org/10.1681/ASN.0000000000000376

Pinter J; Smyth B; Jardine M, 2024, 'Authors' Reply: Dialysate Sodium and Mortality: One Size Does Not Fit All', Journal of the American Society of Nephrology, 35, pp. 977, http://dx.doi.org/10.1681/ASN.0000000000000405

Kim D; Lv J; Hladunewich M; Jha V; Hooi LS; Monaghan H; Shan S; Reich HN; Barbour S; Billot L; Zhang H; Perkovic V; Wong MG; Levin A; Cattran D; Johnson DW; Wheeler D; Flöge J; Woodward M; Jardine M; Zhao MH; Agarwal R; Glassock R; Chan TM; Wu Y; Liu Z, 2024, 'The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy', Kidney International Reports, 9, pp. 2168 - 2179, http://dx.doi.org/10.1016/j.ekir.2024.03.032

Patel SM; Kang YM; Im KA; Neuen BL; Anker SD; Bhatt DL; Butler J; Cherney DZI; Claggett BL; Fletcher RA; Herrington WG; Inzucchi SE; Jardine MJ; Mahaffey KW; McGuire DK; McMurray JJV; Neal B; Packer M; Perkovic V; Solomon SD; Staplin N; Vaduganathan M; Wanner C; Wheeler DC; Zannad F; Zhao Y; Heerspink HJL; Sabatine MS; Wiviott SD, 2024, 'Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis', Circulation, 149, pp. 1789 - 1801, http://dx.doi.org/10.1161/CIRCULATIONAHA.124.069568

Pinter J; Neumaier A; Christa M; Canaud B; Mayne K; Stuard S; Jardine M; Smyth B; Genser B, 2024, '#1657 Impact of cumulative fluid and sodium imbalance exposure on cause-specific mortality in hemodialysis', Nephrology Dialysis Transplantation, 39, http://dx.doi.org/10.1093/ndt/gfae069.808

Fussner LA; Flores-Suárez LF; Cartin-Ceba R; Specks U; Cox PG; Jayne DRW; Merkel PA; Walsh M; Paizis K; Walters G; Jardine M; Milton C; Ibraham A; Siva B; Desmond M; Perkovic V; Kurtkoti J; Vilayur E; Cass A; Summers S; Brown F; Ryan J; Kerr P; Noble E; Luxton G; Mudge DW; Hawley C; Johnson DW; Peh CA; Faull RJ; Ranganathan D; Jeffs L; Nicholls K; Hughes P; Cooper B; Boudville N; Ford S; Langham R; Reidlinger D; Morrish A; Badve SV; Pascoe E; Paul-Brent PA; Robison L; Valks A; Blockmans D; Henckaerts L; Sprangers B; Suri R; Brachemi S; Clark W; Garg A; Carette S; Pagnoux C; Reich H; Barth D; Khalidi N; Cox G; Mazzetti A; Robins D; Wald R; Perl J; Pavenski K; Dacouris N; Levin A; Copland M; Fairhead T; Pannu N; Qarni MU; Habib S; Girard L; Manns B; Tesar V; Hruskova Z; Chocova Z; Povlsen J; Gregersen J; Ivarsen P; Birn H; Krarup E; Pedersen EB; Thomsen I; Bech JN; Szpirt W; Egfjord M; Mesbah R; Bataille P; Rey I; Chantrel F; Vanhille P; Quémeneur T; Carron PL; Zaoui P; de Moreuil C; Gosselin M; Delluc A; Hanrotel-Saliou C; Le Jeune M; Ficheux M; Aniort J, 2024, 'Alveolar Hemorrhage in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Results of an International Randomized Controlled Trial (PEXIVAS)', American Journal of Respiratory and Critical Care Medicine, 209, pp. 1141 - 1151, http://dx.doi.org/10.1164/rccm.202308-1426OC

Januzzi JL; Liu Y; Sattar N; Yavin Y; Pollock CA; Butler J; Jardine M; Heerspink HJL; Masson S; Breyer M; Hansen MK, 2024, 'Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial', American Heart Journal, 271, pp. 38 - 47, http://dx.doi.org/10.1016/j.ahj.2024.02.016

Mohebi R; Liu Y; Hansen MK; Yavin Y; Sattar N; Pollock CA; Butler J; Jardine M; Masson S; Heerspink HJL; Januzzi JL, 2024, 'Associations of Angiopoietin 2 and Vascular Endothelial Growth Factor-A Concentrations with Clinical End Points', Clinical Journal of the American Society of Nephrology, 19, pp. 429 - 437, http://dx.doi.org/10.2215/CJN.0000000000000389

Toussaint ND; Davies CE; Bongetti E; Ruderman I; Elder GJ; Hawley CM; Krishnasamy R; Roberts MA; Jardine MJ; De Zoysa JR; McDonald SP, 2024, 'Calciphylaxis Episodes in the Australia and New Zealand Dialysis and Transplant Registry', Kidney International Reports, 9, pp. 951 - 959, http://dx.doi.org/10.1016/j.ekir.2024.01.026

Francis A; Wainstein M; Irish G; Abdul Hafidz MI; Chen T; Cho Y; Htay H; Kanjanabuch T; Lalji R; Neuen BL; See E; Shah A; Smyth B; Tungsanga S; Viecelli A; Yeung EK; Arruebo S; Bello AK; Caskey FJ; Damster S; Donner JA; Jha V; Johnson DW; Levin A; Malik C; Nangaku M; Okpechi IG; Tonelli M; Ye F; Wong MG; Bavanandan S; Abdul Gafor AH; Amouzegar A; Bennett P; Chicano SL; Davids MR; Davison SN; Diongole HM; Divyaveer S; Ekrikpo UE; Ethier I; Fong VK; Fung WWS; Ghimire A; Gopal B; Phan HAH; Harris DCH; Houston G; Ibrahim KS; Jardine MJ; Jindal K; Kantachuvesiri S; Kelly DM; Kerr P; Kim S; Krishnasamy R; Kwek JL; Lee V; Liew A; Lim CY; Lydia A; Nalado AM; Olanrewaju TO; Osman MA; Petrova A; Pyar KP; Riaz P; Saad S; Sakajiki AM; Sengthavisouk N; Sozio SM; Srisawat N; Tan E; Tiv S; Tomacruz Amante ID; Villanueva AR; Walker R; Walker R; Zaidi D, 2024, 'Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA)', Kidney International Supplements, 13, pp. 110 - 122, http://dx.doi.org/10.1016/j.kisu.2024.01.004

Jenkins AJ; O'Connell RL; Januszewski AS; Webster AC; M.E. Davis T; Jardine MJ; Scott RS; Taskinen MR; Keech AC, 2024, 'Not enough known about fenofibrate's kidney effects in people with Type 2 diabetes', Diabetes Research and Clinical Practice, 210, http://dx.doi.org/10.1016/j.diabres.2024.111612

Smyth B; Krishnasamy R; Jardine M; Hawley C; Jha V; Walsh M; Li Z; Wanner C; Bavanandan S; Wheeler DC; Perkovic V; Rossignol P; Clark C; Kaufman J; Khan BA; Bassi A; Pinter J; Dempsey E; Solano NZ, 2024, 'Are Observational Reports on the Association of Dialysate Sodium with Mortality Enough to Change Practice? Perspective from the RESOLVE Study Team', Journal of the American Society of Nephrology, 35, pp. 229 - 231, http://dx.doi.org/10.1681/ASN.0000000000000289

Koshino A; Neuen BL; Oshima M; Toyama T; Hara A; Arnott C; Neal B; Jardine M; Badve SV; Mahaffey KW; Pollock C; Hansen MK; Wada T; Heerspink HJL, 2024, 'Autoantibodies to Erythropoietin Receptor and Clinical Outcomes in Patients With Type 2 Diabetes and CKD: A Post Hoc Analysis of CREDENCE Trial', Kidney International Reports, 9, pp. 347 - 355, http://dx.doi.org/10.1016/j.ekir.2023.11.024

Pinter J; Smyth B; Stuard S; Jardine M; Wanner C; Rossignol P; Wheeler DC; Marshall MR; Canaud B; Genser B, 2024, 'Effect of Dialysate and Plasma Sodium on Mortality in a Global Historical Hemodialysis Cohort', Journal of the American Society of Nephrology, 35, pp. 167 - 176, http://dx.doi.org/10.1681/ASN.0000000000000262

Neuen BL; Jun M; Wick J; Kotwal S; Badve SV; Jardine MJ; Gallagher M; Chalmers J; Nallaiah K; Perkovic V; Peiris D; Rodgers A; Woodward M; Ronksley PE, 2024, 'Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data', The Lancet Regional Health - Western Pacific, 43, http://dx.doi.org/10.1016/j.lanwpc.2023.100988

Jun M; Wick J; Neuen BL; Kotwal S; Badve SV; Woodward M; Chalmers J; Peiris D; Rodgers A; Nallaiah K; Jardine MJ; Perkovic V; Gallagher M; Ronksley PE, 2024, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', Kidney International Reports, 9, pp. 312 - 322, http://dx.doi.org/10.1016/j.ekir.2023.11.022

Krishnasamy R; Jardine MJ, 2024, 'Adaptive Designs for Clinical Trials in Nephrology', Journal of the American Society of Nephrology, http://dx.doi.org/10.1681/ASN.0000000000000497

Yi TW; O’Hara DV; Smyth B; Jardine MJ; Levin A; Morton RL, 2024, 'Identifying Barriers and Facilitators for Increasing Uptake of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors in British Columbia, Canada, using the Consolidated Framework for Implementation Research', Canadian Journal of Kidney Health and Disease, 11, http://dx.doi.org/10.1177/20543581231217857

Heerspink HJL; Jardine M; Kohan DE; Lafayette RA; Levin A; Liew A; Zhang H; Noronha I; Trimarchi H; Hou FF; Renfurm R; Gray T; Camargo M; Barratt J, 2024, 'Study Design and Baseline Characteristics of ALIGN, a Randomized Controlled Study of Atrasentan in Patients With IgA Nephropathy', Kidney International Reports, http://dx.doi.org/10.1016/j.ekir.2024.10.004

Talbot B; Davies S; Burman J; Ritchie A; Snelling P; Lynch S; Park Y; Jones B; Garvey V; Jaure A; Jardine M; Perkovic V; Gallagher M; Brandwood A; Kaur N; Knight J, 2024, 'The Point-of-Care Peritoneal Dialysis System Early Evaluation Study (POC-PDEE): A pilot proof-of-principal study of the Ellen Medical Devices Point-of-Care affordable peritoneal dialysis system', Peritoneal Dialysis International, http://dx.doi.org/10.1177/08968608231209850

Heerspink HJL; Jardine M; Kohan DE; Lafayette RA; Levin A; Liew A; Zhang H; Gray TE; Sheth K; Renfurm RW; Kocinsky HS; Barratt J, 2024, 'ALIGN Subgroup Analyses: Clinically Meaningful Urinary Protein-to-Creatinine Ratio Reductions across Subgroups', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024d43pbgy5

Siriwardana A; Jardine M; Perkovic V; Jun M; Kotwal SS; Arnott CG; Neuen BL, 2024, 'Cardiovascular, Kidney, and Safety Outcomes with Canagliflozin in Older Adults: A Pooled Secondary Analysis of the CANVAS Program and CREDENCE Trial', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024e59ygyz9

Yi TW; Mallitt K-A; Wilcox A; Puskarich MA; Freilich D; Geriak M; Shikuma CM; Jardine M, 2024, 'Effect of RAAS Inhibitors in People with COVID-19: An Independent Participant Data Meta-Analysis', Journal of the American Society of Nephrology, 35, http://dx.doi.org/10.1681/asn.2024dm6qn9bc

Back to profile page